Scott Antonia

Scott Antonia is Director of the Duke Cancer Institute Centre (DCI) for Cancer Immunotherapy. He is also a professor of medical oncology in the DCI Thoracic Oncology disease group. In his previous roles at H. Lee Moffitt Cancer Center, Scott built an active lung cancer clinical research program and was recognised as Physician of the Year (2005), Mentor of the Year (2008), and Researcher of the Year (2018). Notably, Scott was the global principal investigator for the practice-changing PACIFIC study. He was also the lead investigator of trials that established the clinical activity of immunotherapy for SCLC, which resulted in updated National Comprehensive Cancer Network guidelines. Scott completed his medical training and post-doctoral fellowship in the Flavell Lab at the Yale University School of Medicine.